27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Integra Lifesciences (NASDAQ:IART) remained unaffected after the company reported Q3 results.
Quarterly Results
Earnings per share were up 17.65% year over year to $0.80, which beat the estimate of $0.53.
Revenue of $370,232,000 declined by 2.34% from the same period last year, which beat the estimate of $347,980,000.
Looking Ahead
Integra Lifesciences hasn't issued any earnings guidance for the time being.
Integra Lifesciences hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Oct 28, 2020
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/wzveg3um
Price Action
Company's 52-week high was at $63.23
52-week low: $34.21
Price action over last quarter: down 9.03%
Company Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately 29% of sales internationally, with the remainder 71% derived from the United States.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!